| Ann E Traynor, MD | |
|
261 M 62, Cassopolis, MI 49031-1034 | |
| (269) 445-3874 | |
| Not Available |
| Full Name | Ann E Traynor |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 261 M 62, Cassopolis, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831171768 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | TD061073 (Maine) | Secondary |
| 207R00000X | Internal Medicine | 4301104227 (Michigan) | Primary |
| Entity Name | Mymichigan Medical Center Alma |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265596126 PECOS PAC ID: 3375451404 Enrollment ID: O20040202000975 |
News Archive
As flood waters recede, families along the Gulf Coast need to watch for post-traumatic stress among children and adolescents, says a Virginia Tech expert in trauma psychology in the areas of natural and technological disasters.
Jewish leaders this week pointed to a recent independent study by Penn Medicine at the University of Pennsylvania that found little evidence to support the claim that a circumcision practice known as Metzitzah B'Peh (MBP) leads to an increased likelihood of herpes in infants.
Oligonucleotide-based therapeutics present unique challenges when it comes to testing their potential to cause reproductive and developmental harm. New consensus guidelines for toxicity testing that take into consideration the combined chemical and biological characteristics of these novel biopharmaceuticals are presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
A unique project to develop technology to drive fast and effective drug discovery was announced today by Business Secretary Greg Clark. Based at the Rosalind Franklin Institute in Harwell, Oxfordshire, this new project will pioneer fully-automated hands-free molecular discovery to produce new drugs up to ten times faster and transform the UK's pharmaceutical industry.
The need for a renewable and affordable source of carbon that can sustain future economic development without negatively impacting the environment is now widely recognised. It is also apparent that the increasingly high demand for fossil carbon will eventually deplete existing stocks.
› Verified 5 days ago
| Entity Name | Lakeland Immediate Care Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982677548 PECOS PAC ID: 2264423771 Enrollment ID: O20040524000042 |
News Archive
As flood waters recede, families along the Gulf Coast need to watch for post-traumatic stress among children and adolescents, says a Virginia Tech expert in trauma psychology in the areas of natural and technological disasters.
Jewish leaders this week pointed to a recent independent study by Penn Medicine at the University of Pennsylvania that found little evidence to support the claim that a circumcision practice known as Metzitzah B'Peh (MBP) leads to an increased likelihood of herpes in infants.
Oligonucleotide-based therapeutics present unique challenges when it comes to testing their potential to cause reproductive and developmental harm. New consensus guidelines for toxicity testing that take into consideration the combined chemical and biological characteristics of these novel biopharmaceuticals are presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
A unique project to develop technology to drive fast and effective drug discovery was announced today by Business Secretary Greg Clark. Based at the Rosalind Franklin Institute in Harwell, Oxfordshire, this new project will pioneer fully-automated hands-free molecular discovery to produce new drugs up to ten times faster and transform the UK's pharmaceutical industry.
The need for a renewable and affordable source of carbon that can sustain future economic development without negatively impacting the environment is now widely recognised. It is also apparent that the increasingly high demand for fossil carbon will eventually deplete existing stocks.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ann E Traynor, MD 261 M 62, Cassopolis, MI 49031-1034 Ph: (269) 445-3874 | Ann E Traynor, MD 261 M 62, Cassopolis, MI 49031-1034 Ph: (269) 445-3874 |
News Archive
As flood waters recede, families along the Gulf Coast need to watch for post-traumatic stress among children and adolescents, says a Virginia Tech expert in trauma psychology in the areas of natural and technological disasters.
Jewish leaders this week pointed to a recent independent study by Penn Medicine at the University of Pennsylvania that found little evidence to support the claim that a circumcision practice known as Metzitzah B'Peh (MBP) leads to an increased likelihood of herpes in infants.
Oligonucleotide-based therapeutics present unique challenges when it comes to testing their potential to cause reproductive and developmental harm. New consensus guidelines for toxicity testing that take into consideration the combined chemical and biological characteristics of these novel biopharmaceuticals are presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
A unique project to develop technology to drive fast and effective drug discovery was announced today by Business Secretary Greg Clark. Based at the Rosalind Franklin Institute in Harwell, Oxfordshire, this new project will pioneer fully-automated hands-free molecular discovery to produce new drugs up to ten times faster and transform the UK's pharmaceutical industry.
The need for a renewable and affordable source of carbon that can sustain future economic development without negatively impacting the environment is now widely recognised. It is also apparent that the increasingly high demand for fossil carbon will eventually deplete existing stocks.
› Verified 5 days ago